冻融胚胎移植周期前的子宫内膜容受性阵列检测:系统综述与Meta分析
该系统综述与Meta分析检索PubMed、Web of Science和Embase至2022年2月15日,纳入8项比较研究共2784例患者(ERA组831例,非ERA组1953例),评估冻融胚胎移植前进行子宫内膜容受性阵列(ERA)检测对妊娠结局的影响。结果显示ERA组与非ERA组的活产或持续妊娠率无显著差异(OR 1.38,95%CI 0.79-2.41,I²=83.0%),着床率、生化妊娠率、临床妊娠率和流产率也相当;作者结论认为Meta分析未显示ERA显著改变妊娠率,ERA能否提高妊娠率尚不明确。
要点
- 冻融胚胎移植前ERA组与非ERA组活产或持续妊娠率无显著差异(OR 1.38,95%CI 0.79-2.41)。
- 基于既往胚胎移植失败次数的亚组分析中,ERA与非ERA组妊娠率同样无显著差异。
- 着床率、生化妊娠率、临床妊娠率和流产率在ERA与非ERA组间相当。
核心结论
- 本Meta分析未显示使用ERA后IVF周期妊娠率发生显著变化,ERA能否提高妊娠率尚不明确。
研究设计与样本
- 系统综述与Meta分析,检索PubMed、Web of Science和Embase自建库至2022年2月15日。
- 纳入8项比较研究,共2784例患者,其中ERA组831例,非ERA组1953例。
- 采用Cochrane Q检验和I²统计量评估研究间异质性,采用随机效应模型合并比值比(OR)及95%置信区间(CI)。
- 按既往胚胎移植失败次数(≤2次失败 vs >2次失败,后者定义为反复种植失败)进行亚组分析,并按研究设计和混杂因素调整分别分析。
- 研究已在前瞻性注册于PROSPERO(CRD42022310862)。
主要发现
- ERA组与非ERA组活产或持续妊娠率无显著差异(OR 1.38,95%CI 0.79-2.41,I²=83.0%)。
- 基于既往胚胎移植失败次数的亚组分析中,ERA组与非ERA组妊娠率同样无显著差异。
- 着床率、生化妊娠率、临床妊娠率和流产率在ERA组与非ERA组间相当。
- 按研究设计和混杂因素调整分别分析后,总体合并估计值仍无统计学显著性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the impact of endometrial receptivity array (ERA) before frozen embryo transfer in patients undergoing in vitro fertilization (IVF). There is a lack of consensus regarding the use of ERA for increasing the success rate of IVF cycles, mainly in terms of the live birth rate. DESIGN: PubMed, Web of Science and Embase were searched from inception up to February 15, 2022. SETTING: Not applicable. PATIENT(S): Patients undergoing ERA vs no ERA before frozen embryo transfer. INTERVENTION(S): Only comparative studies evaluating pregnancy rates of patients undergoing frozen embryo transfer cycles with or without prior ERA were included. Inter-study heterogeneity was also assessed using Cochrane's Q test and the I2 statistic. The random-effects model was used to pool the odds ratio (OR) with the corresponding 95% confidence intervals (CIs). Subgroup analyses were performed to investigate the impact of ERA on pregnancy rates according to the number of previous embryo transfer (ET) failures (≤ 2 previous failed ETs vs. > 2 failed ETs, defined as recurrent implantation failure). Separate analyses were performed according to the study design and adjustment for confounders. MAIN OUTCOME MEASURES(S): The primary outcomes of the study were live birth rate and/or ongoing pregnancy rate. Implantation rate, biochemical pregnancy rate, clinical pregnancy rate, and miscarriage rate were considered secondary outcomes. RESULT(S): Eight studies (representing data on n = 2,784 patients; n = 831 had undergone ERA and n = 1,953 without ERA) were found to be eligible for this meta-analysis. The live birth or ongoing pregnancy rate for the ERA group was not significantly different compared with the non-ERA group (OR, 1.38; 95% CI, 0.79-2.41; I2 83.0%), nor was a difference seen in subgroup analyses based on the number of previous failed ETs. The rates of implantation, biochemical pregnancy, clinical pregnancy, and miscarriage were also comparable between the ERA and the non-ERA groups. After separate analyses according to the study design and adjustment for confounding factors, overall pooled estimates remained statistically nonsignificant. CONCLUSION(S): The findings of the current meta-analysis did not reveal a significant change in the rate of pregnancy after IVF cycles using ERA, and it is not clear whether ERA can increase the pregnancy rate or not. SYSTEMATIC REVIEW REGISTRATION: Prospectively registered in PROSPERO (CRD42022310862).
引用
- Arian SE, Hessami K, Khatibi A, et al. Endometrial receptivity array before frozen embryo transfer cycles: a systematic review and meta-analysis. Fertil Steril. 2022. PMID: 36414088. doi:10.1016/j.fertnstert.2022.11.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。